Andree Yeramian Hakim
Degree: PhD
973 70 36 67
andree.yeramian(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/B-5936-2009
Publications
-
Lopez-Mejia IC; Pijuan J; Navaridas R; Santacana M; Gatius S; Velasco A; Castellà G; Panosa A; Cabiscol E; Pinyol M; Coll L; Bonifaci N; Peña LP; Vidal A; Villanueva A; Gari E; Llobet-Navàs D; Fajas L; Matias-Guiu X; Yeramian A
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.
MOLECULAR ONCOLOGY 17 98-118. .
-
Altes, G; Vaquero, M; Cuesta, S; Anerillas, C; Macia, A; Espinet, C; Ribera, J; Bellusci, S; Klein, OD; Yeramian, A; Dolcet, X; Egea, J; Encinas, M
A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes
Cellular And Molecular Life Sciences 79 514-514. .
-
Ruiz-Mitjana, A; Navaridas, R; Vidal-Sabanes, M; Perramon-Guell, A; Yeramian, A; Felip, I; Eritja, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X
Lack of extracellular matrix switches TGF-ß induced apoptosis of endometrial cells to epithelial to mesenchymal transition.
SCIENTIFIC REPORTS 12 14821-14821. .
-
Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.
Cancers 14 -. .
-
Sanchez, E; Santos, MD; Nuñez-Garcia M; Bueno, M; Sajoux, I; Yeramian, A; Lecube, A
Randomized Clinical Trial to Evaluate the Morphological Changes in the Adventitial Vasa Vasorum Density and Biological Markers of Endothelial Dysfunction in Subjects with Moderate Obesity Undergoing a Very Low-Calorie Ketogenic Diet.
Nutrients 14 -. .
-
Sanchez, E; Lecube, A; Betriu À; Hernandez, C; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Kerkeni, M; Yeramian, A; Purroy, F; Pamplona, R; Farràs C; Fernandez, E; Barbe, F; Simo, R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M
Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The MR-1 ILERVAS Project
Diabetes & metabolism 45 595-598. .
-
Lopez-Cano, C; Gutierrez-Carrasquilla, L; Sanchez, E; Gonzalez, J; Yeramian, A; Marti, R; Hernandez, M; Cao, G; Ribelles, M; Gomez, X; Barril, S; Barbe, F; Hernandez, C; Simo, R; Lecube, A
Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes
Frontiers in Endocrinology 10 752-752. .
-
Lopez-Cano, C; Rius, F; Sanchez, E; Gaeta, AM; Betriu À; Fernandez, E; Yeramian, A; Hernandez, M; Bueno, M; Gutierrez-Carrasquilla, L; Dalmases, M; Lecube, A
The influence of sleep apnea syndrome and intermittent hypoxia in carotid adventitial vasa vasorum
PLOS ONE 14 -. .
-
Sanchez, E; Betriu, A; Yeramian, A; Fernandez, E; Purroy, F; Sanchez-de-la-Torre, M; Pamplona, R; Miquel, E; Kerkeni, M; Hernandez, C; Simo, R; Lecube, A; Hernandez, M; Rius, F; Polanco, D; Barbe, F; Torres, G; Suarez, G; Portero-Otin, M; Jove, M; Colas-Campas, L; Benabdelhak, I; Farras, C; Ortega, M; Valdivielso, JM; Bermudez-Lopez, M; Martinez-Alonso, M; ILERVAS Project
Skin Autofluorescence Measurement n Subclinical Atheromatous Disease: Results from the ILERVAS Project
Journal of Atherosclerosis and Thrombosis 26 879-889. .
-
Rius, F; Sanchez, E; Betriu À; Baena-Fustegueras, JA; Yeramian, A; Vidal, T; Hernandez, M; Lopez-Cano, C; Bueno, M; Gutierrez-Carrasquilla, L; Herrerias, F; de la Fuente, MC; Fernandez, E; Lecube, A
Influence of Morbid Obesity and Bariatric Surgery Impact on the Carotid Adventitial Vasa Vasorum Signal
OBESITY SURGERY 28 3935-3942. .
-
Nager, M; Sallan, MC; Visa, A; Pushparaj, C; Santacana, M; Macia, A; Yeramian, A; Canti, C; Herreros, J
Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers
Autophagy 14 619-636. .
-
Eritja, N; Felip, I; Dosil, MA; Vigezzi, L; Mirantes, C; Yeramian, A; Navaridas, R; Santacana, M; Llobet-Navas, D; Yoshimura, A; Nomura, M; Encinas, M; Matias-Guiu, X; Dolcet, X
A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-beta in mouse endometrium
CELL DEATH AND DIFFERENTIATION 24 1443-1458. .
Projects
- ¿CONOCER LA PREDISPOSICION GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- La serine/threonine protein kinase PRK1 en l'adipòcit de pacients amb diabetes (Ajut per a la recerca de la Societat Catalana d'Endocrinologia i Nutrició)
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
- Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
- EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
- Alteraciones moleculares relacionados con la progresión tumoral en el cáncer de endometrio
- MECANISMOS DE REGULACION FLIP Y LA RESPUESTA A TRAIL EN EL DESARROLLO Y PROGRESION DEL CANCER
- Caracterización de las células neoplásicas inmaduras pluripotenciales (células madre neoplásicas) en el cáncer de endometrio. Implicaciones Patogénicas, pronósticas y terapeuticas
